Two hearings have been scheduled by the US PTO on the effect of patents for Genetic Testing, to support the study that the PTO is mandated by the Leahy-Smith America Invents Act (“AIA”) to generate for Congress.
The first of the hearings is today. It will be broadcast via the Web.
The second of the hearings will be March 9 in San Diego. My colleague Prof. Chris Holman, incoming Executive Editor of Biotechnology Law Report, is scheduled to testify at that hearing.
Each of these agendas provides the logon information for the web broadcasts of the hearings.
Further information from the US Patent and Trademark Office on implementation of the America Invents Act is available here.